Pershing Square Submiterd Additional Special Meeting Requests On Friday, Total Submitted Represents 35.68% Of Allergan Shares

Loading...
Loading...
Pershing Square Capital Management, L.P. (“Pershing Square”), the largest shareholder of Allergan, Inc.
AGN
(“Allergan”), announced that on Friday it submitted to Allergan additional special meeting requests from shareholders owning approximately 0.6% of Allergan's shares. With these requests, Pershing Square has delivered requests from 51 institutions representing 35.68% of the outstanding common stock of Allergan. At the special meeting, Allergan shareholders will have the opportunity to voice their support for a number of critical matters, including the removal of six incumbent members of the Allergan board, the appointment of an independent slate of directors, amendments to Allergan's bylaws to eliminate onerous restrictions on the calling of a special meeting, a request that Allergan engage in negotiations with Valeant Pharmaceuticals International, Inc.
VRX
(“Valeant”) and Pershing Square, and certain other actions to improve corporate governance of Allergan. To learn more about the special meeting and the Pershing Square and Valeant bid for Allergan, as well as related court cases in the Delaware Court of Chancery and the U.S. District Court Central District of California, please go to http://advancingallergan.com/.
Posted In: NewsPress Releases
We simplify the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...